Frontlight ResearchEarly access
Kidney cancer trials in Hong Kong
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - No phaseTaking peopleEUS-guided RFA for Solid Abdominal Neoplasms
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 30
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT03221335